Mohammadi, M.; Saha, A.; Giles-Davis, W.; Xiang, Z.; Novikov, M.; Hasanpourghadi, M.; C. J. Ertl, H.
Preclinical Immunogenicity and Efficacy Studies for Therapeutic Vaccines for Human Papillomavirus-Type-16-Associated Cancer. Vaccines 2024, 12, 616.
https://doi.org/10.3390/vaccines12060616
AMA Style
Mohammadi M, Saha A, Giles-Davis W, Xiang Z, Novikov M, Hasanpourghadi M, C. J. Ertl H.
Preclinical Immunogenicity and Efficacy Studies for Therapeutic Vaccines for Human Papillomavirus-Type-16-Associated Cancer. Vaccines. 2024; 12(6):616.
https://doi.org/10.3390/vaccines12060616
Chicago/Turabian Style
Mohammadi, Mohsen, Amara Saha, Wynetta Giles-Davis, Zhiquan Xiang, Mikhail Novikov, Mohadeseh Hasanpourghadi, and Hildegund C. J. Ertl.
2024. "Preclinical Immunogenicity and Efficacy Studies for Therapeutic Vaccines for Human Papillomavirus-Type-16-Associated Cancer" Vaccines 12, no. 6: 616.
https://doi.org/10.3390/vaccines12060616
APA Style
Mohammadi, M., Saha, A., Giles-Davis, W., Xiang, Z., Novikov, M., Hasanpourghadi, M., & C. J. Ertl, H.
(2024). Preclinical Immunogenicity and Efficacy Studies for Therapeutic Vaccines for Human Papillomavirus-Type-16-Associated Cancer. Vaccines, 12(6), 616.
https://doi.org/10.3390/vaccines12060616
